To optimize glycemic control and enhance the quality of life for patients with T2DM, targeted interventions that focus on elderly patients, those with longer durations of diabetes and complications, obese patients, and those on insulin therapy should be implemented. The gene discussed is INS; the disease is diabetes mellitus.